Viveve Medical (NASDAQ:VIVE – Get Rating) will be posting its quarterly earnings results after the market closes on Thursday, May 12th. Individual interested in participating in the company’s earnings conference call can do so using this link.
Viveve Medical (NASDAQ:VIVE – Get Rating) last released its earnings results on Thursday, March 17th. The company reported ($0.72) earnings per share for the quarter. Viveve Medical had a negative return on equity of 105.11% and a negative net margin of 360.19%. The business had revenue of $1.71 million during the quarter. On average, analysts expect Viveve Medical to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
VIVE stock opened at $0.89 on Thursday. The company has a quick ratio of 4.58, a current ratio of 4.91 and a debt-to-equity ratio of 0.34. The business’s fifty day simple moving average is $0.96 and its two-hundred day simple moving average is $1.29. Viveve Medical has a twelve month low of $0.78 and a twelve month high of $3.22. The firm has a market cap of $9.42 million, a price-to-earnings ratio of -0.33 and a beta of 0.64.
Institutional investors have recently made changes to their positions in the company. Dimensional Fund Advisors LP purchased a new position in shares of Viveve Medical during the third quarter valued at $38,000. Morgan Stanley increased its stake in shares of Viveve Medical by 203,916.7% during the third quarter. Morgan Stanley now owns 24,482 shares of the company’s stock valued at $56,000 after buying an additional 24,470 shares during the period. Citadel Advisors LLC purchased a new position in shares of Viveve Medical during the fourth quarter valued at $32,000. Millennium Management LLC purchased a new position in shares of Viveve Medical during the fourth quarter valued at $32,000. Finally, Virtu Financial LLC increased its stake in shares of Viveve Medical by 234.1% during the fourth quarter. Virtu Financial LLC now owns 35,028 shares of the company’s stock valued at $40,000 after buying an additional 24,543 shares during the period. Hedge funds and other institutional investors own 19.25% of the company’s stock.
About Viveve Medical (Get Rating)
Viveve Medical, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components.
- Get a free copy of the StockNews.com research report on Viveve Medical (VIVE)
- MarketBeat Podcast: Alternative Investing Strategies Despite Market Volatility
- Limelight Networks Stock is a Speculative Turnaround Opportunity
- The Selloff In SiteOne Landscape Supply Is Overextended
- Camping World Confirms Support At Institutional Bottom
- What’s Next For Starbucks (NASDAQ: SBUX)?
Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.